While all men are at risk for prostate cancer, there are disproportionate gaps in treatment, research, clinical trials and mortality rates among African American men that need to be recognized and can be addressed with the aid of AI
Related Articles
Fierce Healthcare Fundraising Tracker—Cancer-testing startup Artera banks $90M; ‘Radiology...
The maker of AI-based prognostic cancer tests is led by its flagship offering ArteraAI Prostate Test. The test is at the fore [...]
ArteraAI Validates its Prognostic Model in Advanced Prostate Cancer
ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announces [...]